Auvi-Q® (epinephrine injection) Voluntary Recall

Sanofi US announced that the company is voluntarily recalling ALL Auvi-Q® (epinephrine injection, USP) currently on the market, including both the 0.15 mg and 0.3 mg strengths. This includes those distributed between January 13, 2015 and October 23, 2015 corresponding to lot numbers 2299596 through 3037230, which expire March 2016 through December 2016. 

Sanofi US initiated the recall due to issues discovered during routine manufacturing quality review at a contract manufacturer.   The products have been found to potentially have inaccurate dosage delivery. 

If you have an Auvi-Q device, please contact the office so that we may provide you with a prescription for an alternate epinephrine auto-injector. 

Please follow the link below for further information, including information on how to return your Auvi-Q devices and for potential reimbursement.
-Auvi-Q Recall Press Release